NPCE Neuropace, Inc. - Common Stock
NASDAQ · Health Care · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 11, 2026
$12.70
· % 处于52周区间
· 高于低点
· 至高点
$9.2252周低点
$19.6052周高点
市值 (MRQ)
$435M
P/E (TTM)
-22.3
EPS (TTM)
$-0.57
收入 (TTM)
$99M
NPCE 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$12.70
市值 (MRQ)
$435M
P/E (TTM)
-22.3
EPS (TTM)
$-0.57
收入 (TTM)
$99M
ROE (TTM)
-122.1%
负债/权益 (MRQ)
5.0
52周区间
$9–$20
NPCE 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
关于 Neuropace, Inc. - Common Stock 公司概况（来自维基百科）
行业板块Health Care
行业Health Care
员工220
国家US
10年表现 收入、净利润、利润率和每股收益趋势
收入$100M2020-12-31 → 2025-12-31
EPS$-0.662020-12-31 → 2025-12-31
自由现金流$-11M2021-12-31 → 2025-12-31
净利率-19.3%2021-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | NPCE | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | -22.35年均值 ≈-9.8 | ≈-9.8 | · | · | |
| P/S (TTM) | 4.45年均值 ≈4.0 | ≈4.0 | 4.2 | 估值过高 | |
| 市净率 (MRQ) | 36.65年均值 ≈17.5 | ≈17.5 | 3.5 | 估值过高 | |
| EV / EBITDA (企业价值 / EBITDA) | -26.25年均值 ≈-13.1 | ≈-13.1 | · | · | |
| 股价/自由现金流 (TTM) | -37.55年均值 ≈-17.9 | ≈-17.9 | · | · | |
| 市现率 (TTM) | -38.75年均值 ≈-18.3 | ≈-18.3 | · | · | |
| 市值/营收 (TTM) | 4.55年均值 ≈3.6 | ≈3.6 | · | · | |
| 市值/自由现金流 (TTM) | -38.15年均值 ≈-17.2 | ≈-17.2 | · | · | |
| Price / Tangible Book (市净率（有形资产）) | 22.65年均值 ≈17.5 | ≈17.5 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | NPCE | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 毛利率 (TTM) | 79.6%5年均值 ≈74.0% | ≈74.0% | 76.2% | 顶尖 | |
| 营业利润率 (TTM) | -15.3%5年均值 ≈-45.4% | ≈-45.4% | -14.5% | 弱 | |
| EBITDA Margin (息税折旧摊销前利润率) | -16.3%5年均值 ≈-45.4% | ≈-45.4% | -14.5% | 弱 | |
| 净利润率 (TTM) | -19.3%5年均值 ≈-57.8% | ≈-57.8% | -15.2% | 弱 | |
| ROA (TTM) | -18.8%5年均值 ≈-30.8% | ≈-30.8% | -17.4% | 低于平均水平 | |
| ROE (TTM) | -122.1%5年均值 ≈-152.2% | ≈-152.2% | -39.3% | 弱 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | NPCE | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 负债/股东权益比率 (MRQ) | 5.05年均值 ≈3.1 | ≈3.1 | 0.7 | 高负债 | |
| 流动比率 (MRQ) | 4.95年均值 ≈7.9 | ≈7.9 | 4.8 | 持平 | |
| 速动比率 (MRQ) | 3.85年均值 ≈6.9 | ≈6.9 | 3.7 | 持平 | |
| 长期负债/股东权益 (MRQ) | 5.05年均值 ≈3.1 | ≈3.1 | 0.6 | 高负债 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | NPCE | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 25.1%5年均值 ≈20.3% | ≈20.3% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 30.0%5年均值 ≈22.5% | ≈22.5% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | 19.4% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | NPCE | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 1.05年均值 ≈0.6 | ≈0.6 | 0.7 | 顶尖 | |
| Inventory Turnover (库存周转率) | 1.55年均值 ≈1.6 | ≈1.6 | 2.3 | 弱 | |
| Receivables Turnover (应收账款周转率) | 7.35年均值 ≈6.5 | ≈6.5 | 7.0 | 持平 | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$454.5K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
20.1%
下次报告
十一月 02, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 10, 2026 | $-0.18 | $-0.21 | 14.6% |
| 2026年3月31日 | 五月 11, 2026 | $-0.20 | $-0.23 | 12.4% |
| 2025年12月31日 | $-0.08 | $-0.15 | 48.2% | |
| 2025年9月30日 | $-0.11 | $-0.20 | 45.1% | |
| 2025年6月30日 | $-0.26 | $-0.23 | -14.5% | |
| 2025年3月31日 | $-0.21 | $-0.25 | 14.7% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $100M | $80M | $65M | $46M | $45M | $41M | |
| Cost of Revenue | $23M | $21M | $17M | $13M | $12M | $11M | |
| Gross Profit | $77M | $59M | $48M | $32M | $33M | $30M | |
| R&D Expense | $28M | $24M | $21M | $22M | $18M | $16M | |
| SG&A Expense | $19M | $17M | $55M | $51M | $39M | $28M | |
| Operating Expenses | $94M | $81M | $75M | $73M | $57M | $43M | |
| Operating Income | $-16M | $-22M | $-27M | $-41M | $-24M | $-13M | |
| Interest Expense | · | · | $9M | $8M | $7M | $11M | |
| Interest Income | $3M | $3M | $3M | $2M | $448.0K | $41.0K | |
| Other Non-op | $-486.0K | $304.0K | $-315.0K | $-337.0K | $-5M | $218.0K | |
| Income Tax | $0 | · | · | · | · | · | |
| Net Income | $-21M | $-27M | $-33M | $-47M | $-36M | $-24M | |
| EPS (Basic) | $-0.66 | $-0.93 | $-1.27 | $-1.91 | $-2.17 | $-117.85 | |
| EPS (Diluted) | $-0.66 | $-0.93 | $-1.27 | $-1.91 | $-2.17 | $-117.85 | |
| Shares (Basic) | 32,722,438 | 29,126,314 | 25,851,813 | 24,594,784 | 16,608,800 | 204,068 | |
| Shares (Diluted) | 32,722,438 | 29,126,314 | 25,851,813 | 24,594,784 | 16,608,800 | 204,068 | |
| EBITDA | $-16M | $-22M | $-27M | $-41M | $-24M | · |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $22M | $13M | $18M | $7M | $19M | $26M | |
| Short-term Investments | $39M | $39M | $48M | $71M | $96M | $12M | |
| Receivables | $13M | $13M | $12M | $7M | $7M | $8M | |
| Inventory | $15M | $13M | $11M | $10M | $8M | $7M | |
| Prepaid Expense | $1M | $2M | $3M | $3M | $2M | $1M | |
| Current Assets | $94M | $81M | $93M | $98M | $133M | $55M | |
| PP&E (Net) | $1M | $1M | $1M | $1M | $603.0K | $515.0K | |
| PP&E (Gross) | $9M | $9M | $9M | $10M | $9M | $9M | |
| Accum. Depreciation | $8M | $8M | $8M | $9M | $8M | $8M | |
| Other Non-current Assets | $113.0K | $15.0K | $15.0K | $21.0K | $21.0K | $23.0K | |
| Total Assets | $106M | $95M | $108M | $114M | $134M | $56M | |
| Accounts Payable | $2M | $3M | $2M | $2M | $1M | $949.0K | |
| Accrued Liabilities | $13M | $10M | $11M | $7M | $8M | $7M | |
| Current Liabilities | $18M | $15M | $16M | $11M | $9M | $10M | |
| Capital Leases | $10M | $12M | $14M | $15M | $0 | · | |
| Other Non-current Liabilities | · | · | · | · | $0 | $274.0K | |
| Total Liabilities | $87M | $87M | $87M | $79M | $60M | $62M | |
| Long-term Debt | · | · | · | · | $50M | $53M | |
| Total Debt | $59M | $60M | $57M | $53M | $50M | · | |
| Common Stock | $34.0K | $30.0K | $28.0K | $25.0K | $24.0K | $0 | |
| Paid-in Capital | $571M | $539M | $524M | $507M | $498M | $240M | |
| Retained Earnings | $-552M | $-531M | $-504M | $-471M | $-424M | $-388M | |
| AOCI | · | · | $0 | $-1M | $-272.0K | $33.0K | |
| Stockholders' Equity | $19M | $8M | $21M | $35M | $74M | $-148M | |
| Liabilities + Equity | $106M | $95M | $108M | $114M | $134M | $56M | |
| Shares Outstanding | 33,574,759 | 30,145,039 | 27,823,465 | 25,045,751 | 24,452,999 | 314,096 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $11M | $10M | $10M | $8M | $4M | $1M | |
| Operating Cash Flow | $-11M | $-18M | $-20M | $-37M | $-25M | $-22M | |
| CapEx | $332.0K | $306.0K | $173.0K | $603.0K | $384.0K | $62.0K | |
| Investing Cash Flow | $-332.0K | $9M | $23M | $24M | $-85M | $-11M | |
| Stock Repurchased | $50M | $0 | · | · | · | · | |
| Net Stock Activity | $-50M | · | · | · | · | · | |
| Financing Cash Flow | $20M | $4M | $8M | $490.0K | $103M | $55M | |
| Net Change in Cash | $8M | $-5M | $11M | $-13M | $-7M | $23M | |
| Free Cash Flow | $-11M | $-18M | $-20M | $-37M | $-25M | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 77.2% | 73.9% | 73.6% | 71.4% | 74.0% | · | |
| Operating Margin | -16.3% | -27.1% | -41.5% | -89.6% | -52.5% | · | |
| Net Margin | -21.5% | -34.0% | -50.4% | -103.4% | -79.8% | · | |
| EBITDA Margin | -16.3% | -27.1% | -41.5% | -89.6% | -52.5% | · | |
| ROA | -21.4% | -26.8% | -29.7% | -38.0% | -38.1% | · | |
| ROE | -111.6% | -304.3% | -178.1% | -120.4% | -46.5% | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 5.3 | 5.4 | 5.7 | 8.9 | 14.3 | · | |
| Quick Ratio | 4.3 | 4.3 | 4.9 | 7.7 | 13.2 | · | |
| Debt / Equity | 3.1 | 7.4 | 2.8 | 1.5 | 0.7 | · | |
| LT Debt / Equity | 3.1 | 7.4 | 2.8 | 1.5 | 0.7 | · | |
| Interest Coverage | · | · | -3.2 | -5.4 | -3.2 | · |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 0.8 | 0.6 | 0.4 | 0.5 | · | |
| Inventory Turnover | 1.5 | 1.7 | 1.7 | 1.5 | 1.6 | · | |
| Receivables Turnover | 7.3 | 6.4 | 6.6 | 6.2 | 5.8 | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.57 | $0.27 | $0.74 | $1.39 | $3.01 | · | |
| Revenue / Share | $3.06 | $2.74 | $2.53 | $1.85 | $2.72 | · | |
| Cash Flow / Share | $-0.34 | $-0.62 | $-0.76 | $-1.50 | $-1.48 | · | |
| Cash / Share | $0.65 | $0.45 | $0.65 | $0.26 | $0.78 | · | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | · | · | · | |
| EPS (TTM) | $-0.66 | $-0.93 | $-1.27 | $-1.91 | $-2.17 | · |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 25.1% | 22.1% | 43.7% | 0.75% | 9.8% | · | |
| Revenue CAGR 3Y | 30.0% | 20.9% | 16.7% | · | · | · | |
| Revenue CAGR 5Y | 19.4% | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $100M | $80M | $65M | $46M | $45M | · | |
| Net Income TTM | $-21M | $-27M | $-33M | $-47M | $-36M | · | |
| Market Cap | $518M | $337M | $287M | $37M | $246M | · | |
| Enterprise Value | $516M | $344M | $277M | $13M | $181M | · | |
| P/E | -23.4 | -12.0 | -8.1 | -0.8 | -4.6 | · | |
| P/S | 5.2 | 4.2 | 4.4 | 0.8 | 5.5 | · | |
| P/B | 27.2 | 42.1 | 13.9 | 1.1 | 3.4 | · | |
| P / Tangible Book | 27.2 | 42.1 | 13.9 | 1.1 | 3.4 | · | |
| P / Cash Flow | -47.1 | -18.8 | -14.6 | -1.0 | -10.0 | · | |
| P / FCF | -45.7 | -18.5 | -14.4 | -1.0 | -9.9 | · | |
| EV / EBITDA | -31.6 | -15.9 | -10.2 | -0.3 | -7.6 | · | |
| EV / FCF | -45.5 | -18.8 | -14.0 | -0.3 | -7.2 | · | |
| EV / Revenue | 5.2 | 4.3 | 4.2 | 0.3 | 4.0 | · | |
| Earnings Yield | -4.3% | -8.3% | -12.3% | -128.2% | -21.5% | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $23M | $22M | $27M | $27M | $20M | $23M | $21M | $21M | $19M | $18M | $18M | $16M | $17M | $14M | $13M | $11M | |
| Cost of Revenue | $4M | $4M | $6M | $6M | $3M | $5M | $5M | $6M | $5M | $5M | $4M | $4M | $5M | $4M | $4M | $3M | |
| Gross Profit | $19M | $18M | $21M | $21M | $16M | $17M | $16M | $15M | $14M | $13M | $14M | $12M | $12M | $10M | $9M | $8M | |
| R&D Expense | $7M | $7M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $6M | |
| SG&A Expense | $5M | $5M | $-7M | $5M | $6M | $4M | $-6M | $4M | $5M | $15M | $13M | $13M | $14M | $13M | $14M | $13M | |
| Operating Expenses | $24M | $24M | $22M | $24M | $24M | $22M | $20M | $20M | $20M | $21M | $19M | $18M | $20M | $19M | $19M | $18M | |
| Operating Income | $-5M | $-6M | $-2M | $-3M | $-8M | $-5M | $-4M | $-4M | $-6M | $-8M | $-5M | $-6M | $-8M | $-8M | $-10M | $-10M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $2M | · | $2M | $2M | $2M | $2M | $2M | |
| Interest Income | $523.0K | $565.0K | $638.0K | $667.0K | $718.0K | $793.0K | $681.0K | $754.0K | $762.0K | $827.0K | $822.0K | $769.0K | $733.0K | $726.0K | $800.0K | $423.0K | |
| Other Non-op | $-41.0K | $-165.0K | $0 | $82.0K | $-486.0K | $-82.0K | $-86.0K | $219.0K | $120.0K | $51.0K | $265.0K | $115.0K | $122.0K | $-817.0K | $-146.0K | $-103.0K | |
| Income Tax | · | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income | $-6M | $-7M | $-3M | $-3M | $-9M | $-7M | $-5M | $-5M | $-8M | $-9M | $-6M | $-7M | $-9M | $-10M | $-11M | $-12M | |
| EPS (Basic) | $-0.18 | $-0.20 | $-0.08 | $-0.11 | $-0.26 | $-0.21 | $-0.16 | $-0.19 | $-0.26 | $-0.32 | $-0.22 | $-0.28 | $-0.36 | $-0.41 | $-0.44 | $-0.48 | |
| EPS (Diluted) | $-0.18 | $-0.20 | $-0.08 | $-0.11 | $-0.26 | $-0.21 | $-0.16 | $-0.19 | $-0.26 | $-0.32 | $-0.22 | $-0.28 | $-0.36 | $-0.41 | $-0.44 | $-0.48 | |
| Shares (Basic) | 34,104,430 | 33,716,813 | · | 33,134,606 | 32,863,031 | 31,480,911 | · | 29,444,625 | 28,853,216 | 28,285,176 | · | 26,017,329 | 25,472,526 | 25,097,262 | · | 24,728,701 | |
| Shares (Diluted) | 34,104,430 | 33,716,813 | · | 33,134,606 | 32,863,031 | 31,480,911 | · | 29,444,625 | 28,853,216 | 28,285,176 | · | 26,017,329 | 25,472,526 | 25,097,262 | · | 24,728,701 | |
| EBITDA | $-5M | $-6M | · | $-3M | $-7M | $-5M | · | $-4M | $-6M | $-8M | · | $-6M | $-8M | $-8M | · | $-10M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $15M | $22M | $21M | $23M | $27M | $13M | $15M | $13M | $13M | $18M | $10M | $8M | $7M | $7M | $6M | |
| Short-term Investments | $39M | $39M | $39M | $39M | $39M | $39M | $39M | $41M | $43M | $46M | $48M | $52M | $56M | $61M | $71M | · | |
| Receivables | $15M | $15M | $15M | $15M | $14M | $15M | $13M | $12M | $11M | $12M | $12M | $11M | $11M | $9M | $7M | $8M | |
| Inventory | $18M | $17M | $17M | $18M | $16M | $14M | $13M | $12M | $11M | $11M | $11M | $10M | $10M | $11M | $10M | $9M | |
| Prepaid Expense | $1M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $3M | $3M | $3M | |
| Current Assets | $86M | $87M | $94M | $95M | $94M | $97M | $81M | $83M | $80M | $84M | $93M | $84M | $87M | $90M | $98M | $104M | |
| PP&E (Net) | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $998.0K | $1M | $1M | $949.0K | $976.0K | $1M | $1M | $894.0K | |
| PP&E (Gross) | $10M | $10M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $10M | $10M | $10M | $10M | $10M | |
| Accum. Depreciation | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $9M | $9M | $9M | $9M | $9M | |
| Other Non-current Assets | $98.0K | $106.0K | $113.0K | $120.0K | $87.0K | $15.0K | $15.0K | $15.0K | $15.0K | $15.0K | $15.0K | $15.0K | $21.0K | $21.0K | $21.0K | $21.0K | |
| Total Assets | $97M | $99M | $106M | $107M | $106M | $110M | $95M | $96M | $94M | $99M | $108M | $99M | $102M | $106M | $114M | $120M | |
| Accounts Payable | $4M | $5M | $2M | $5M | $5M | $4M | $3M | $2M | $2M | $3M | $2M | $1M | $2M | $2M | $2M | $1M | |
| Accrued Liabilities | $11M | $9M | $13M | $12M | $10M | $8M | $10M | $10M | $8M | $7M | $11M | $10M | $8M | $7M | $7M | $8M | |
| Current Liabilities | $17M | $16M | $18M | $20M | $17M | $15M | $15M | $15M | $13M | $13M | $16M | $13M | $12M | $10M | $11M | $9M | |
| Capital Leases | $9M | $9M | $10M | $10M | $11M | $11M | $12M | $12M | $13M | $13M | $14M | $14M | $15M | $15M | $15M | $16M | |
| Total Liabilities | $85M | $84M | $87M | $89M | $87M | $86M | $87M | $86M | $85M | $85M | $87M | $83M | $81M | $79M | $79M | $77M | |
| Total Debt | $59M | $59M | · | $59M | $59M | $60M | · | $59M | $59M | $58M | · | $56M | $55M | $54M | · | $52M | |
| Common Stock | $34.0K | $34.0K | $34.0K | $33.0K | $33.0K | $33.0K | $30.0K | $30.0K | $29.0K | $29.0K | $28.0K | $26.0K | $26.0K | $25.0K | $25.0K | $25.0K | |
| Paid-in Capital | $577M | $574M | $571M | $568M | $566M | $562M | $539M | $535M | $530M | $527M | $524M | $514M | $512M | $509M | $507M | $504M | |
| Retained Earnings | $-565M | $-559M | $-552M | $-550M | $-546M | $-538M | $-531M | $-526M | $-520M | $-513M | $-504M | $-498M | $-490M | $-481M | $-471M | $-460M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $-1M | $-1M | |
| Stockholders' Equity | $12M | $14M | $19M | $19M | $19M | $24M | $8M | $10M | $10M | $14M | $21M | $16M | $21M | $27M | $35M | $43M | |
| Liabilities + Equity | $97M | $99M | $106M | $107M | $106M | $110M | $95M | $96M | $94M | $99M | $108M | $99M | $102M | $106M | $114M | $120M | |
| Shares Outstanding | 34,282,567 | 33,909,408 | 33,574,759 | 33,280,887 | 33,044,371 | 32,751,240 | 30,145,039 | 29,777,966 | 29,139,206 | 28,717,452 | 27,823,465 | 26,244,935 | 25,816,929 | 25,352,204 | 25,045,751 | 24,864,119 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $3M | $2M | $2M | $2M | |
| Operating Cash Flow | $-4M | $-6M | $506.0K | $-2M | $-2M | $-7M | $-5M | $-2M | $-4M | $-8M | $-3M | $-2M | $-4M | $-10M | $-8M | $-7M | |
| CapEx | $125.0K | $117.0K | $97.0K | $30.0K | $168.0K | $37.0K | $39.0K | $100.0K | $63.0K | $104.0K | $32.0K | $9.0K | $0 | $132.0K | $102.0K | $31.0K | |
| Investing Cash Flow | $-125.0K | $-117.0K | $-97.0K | $-30.0K | $-168.0K | $-37.0K | $2M | $1M | $3M | $2M | $3M | $4M | $5M | $10M | $9M | $7M | |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 | $50M | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | · | $0 | · | · | · | $-50M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $1M | $-166.0K | $635.0K | $-235.0K | $-2M | $21M | $848.0K | $3M | $509.0K | $72.0K | $8M | $-27.0K | $195.0K | $-255.0K | $-138.0K | $-8.0K | |
| Net Change in Cash | $-3M | $-6M | $1M | $-2M | $-4M | $14M | $-2M | $3M | $-154.0K | $-5M | $8M | $2M | $1M | $115.0K | $917.0K | $-14.0K | |
| Free Cash Flow | · | $-6M | · | · | · | $-8M | · | · | · | $-8M | · | · | · | $-10M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 82.8% | 81.8% | · | 77.4% | 77.1% | 77.0% | · | 73.2% | 73.4% | 73.6% | · | 74.5% | 72.5% | 71.7% | · | 71.4% | |
| Operating Margin | -22.5% | -25.2% | · | -9.5% | -29.0% | -22.9% | · | -20.2% | -32.4% | -41.6% | · | -36.2% | -47.6% | -57.5% | · | -91.4% | |
| Net Margin | -27.2% | -30.3% | · | -12.8% | -36.8% | -29.2% | · | -25.9% | -39.0% | -49.2% | · | -44.2% | -55.3% | -71.7% | · | -105.6% | |
| EBITDA Margin | -22.5% | -25.2% | · | -9.5% | -29.0% | -22.9% | · | -20.2% | -32.4% | -41.6% | · | -36.2% | -47.6% | -57.5% | · | -91.4% | |
| ROA | -6.1% | -6.4% | · | -3.4% | -8.6% | -6.3% | · | -5.6% | -7.6% | -8.7% | · | -6.6% | -8.3% | -8.8% | · | -9.0% | |
| ROE | -39.6% | -34.5% | · | -24.7% | -59.0% | -34.1% | · | -41.6% | -48.3% | -42.7% | · | -24.3% | -24.6% | -23.0% | · | -18.8% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.9 | 5.4 | · | 4.9 | 5.5 | 6.6 | · | 5.6 | 6.4 | 6.4 | · | 6.6 | 7.5 | 9.1 | · | 11.1 | |
| Quick Ratio | 3.8 | 4.3 | · | 3.8 | 4.4 | 5.6 | · | 4.6 | 5.3 | 5.4 | · | 5.7 | 6.5 | 7.8 | · | 1.4 | |
| Debt / Equity | 5.0 | 4.1 | · | 3.2 | 3.0 | 2.5 | · | 6.0 | 6.0 | 4.0 | · | 3.4 | 2.6 | 2.0 | · | 1.2 | |
| LT Debt / Equity | 5.0 | 4.1 | · | 3.2 | 3.0 | 2.5 | · | 6.0 | 6.0 | 4.0 | · | 3.4 | 2.6 | 2.0 | · | 1.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -3.3 | · | -2.7 | -3.7 | -4.2 | · | -5.4 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.3 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.2 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.4 | · | 0.5 | 0.5 | 0.4 | · | 0.4 | |
| Receivables Turnover | 1.6 | 1.5 | · | 2.1 | 1.9 | 1.7 | · | 1.8 | 1.7 | 1.7 | · | 1.7 | 1.7 | 1.6 | · | 1.5 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.35 | $0.43 | · | $0.56 | $0.59 | $0.74 | · | $0.33 | $0.34 | $0.50 | · | $0.62 | $0.82 | $1.08 | · | $1.75 | |
| Revenue / Share | $0.67 | $0.65 | · | $0.83 | $0.72 | $0.72 | · | $0.72 | $0.67 | $0.64 | · | $0.63 | $0.65 | $0.58 | · | $0.45 | |
| Cash Flow / Share | · | $-0.17 | · | · | · | $-0.24 | · | · | · | $-0.27 | · | · | · | $-0.39 | · | · | |
| Cash / Share | $0.37 | $0.44 | · | $0.62 | $0.69 | $0.82 | · | $0.52 | $0.44 | $0.45 | · | $0.37 | $0.30 | $0.27 | · | $0.23 | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | · | · | · | · | · | · | · | · | · | · | |
| EPS (TTM) | $-0.57 | $-0.65 | · | $-0.74 | $-0.82 | $-0.82 | · | $-0.99 | $-1.08 | $-1.18 | · | $-1.49 | $-1.69 | $-1.85 | · | $29.91 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $99M | $96M | · | $91M | $85M | $84M | · | $76M | $72M | $69M | · | $60M | $55M | $49M | · | $44M | |
| Net Income TTM | $-19M | $-22M | · | $-24M | $-26M | $-25M | · | $-28M | $-30M | $-32M | · | $-38M | $-42M | $-46M | · | $-47M | |
| Market Cap | $545M | $446M | · | $343M | $368M | $403M | · | $208M | $220M | $379M | · | $255M | $116M | $118M | · | $93M | |
| Enterprise Value | $552M | $451M | · | $342M | $365M | $396M | · | $210M | $224M | $378M | · | $250M | $107M | $104M | · | $140M | |
| P/E | -27.9 | -20.2 | · | -13.9 | -13.6 | -15.0 | · | -7.0 | -7.0 | -11.2 | · | -6.5 | -2.7 | -2.5 | · | 0.1 | |
| P/S | 5.5 | 4.7 | · | 3.8 | 4.4 | 4.8 | · | 2.7 | 3.1 | 5.5 | · | 4.2 | 2.1 | 2.4 | · | 2.1 | |
| P/B | 45.8 | 30.9 | · | 18.5 | 18.9 | 16.6 | · | 21.1 | 22.3 | 26.4 | · | 15.6 | 5.5 | 4.3 | · | 2.1 | |
| P / Tangible Book | 45.8 | 30.9 | · | 18.5 | 18.9 | 16.6 | · | 21.1 | 22.3 | 26.4 | · | 15.6 | 5.5 | 4.3 | · | 2.1 | |
| P / Cash Flow | · | -75.6 | · | · | · | -53.8 | · | · | · | -50.4 | · | · | · | -12.1 | · | · | |
| EV / Revenue | 5.6 | 4.7 | · | 3.8 | 4.3 | 4.7 | · | 2.7 | 3.1 | 5.5 | · | 4.2 | 2.0 | 2.1 | · | 3.2 | |
| Earnings Yield | -3.6% | -4.9% | · | -7.2% | -7.4% | -6.7% | · | -14.2% | -14.3% | -8.9% | · | -15.3% | -37.6% | -39.9% | · | 797.6% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $100M | $80M | $65M | $46M | $45M |
| 毛利率 % | 77.2% | 73.9% | 73.6% | 71.4% | 74.0% |
| 营业利润率 % | -16.3% | -27.1% | -41.5% | -89.6% | -52.5% |
| 净收入 | $-21M | $-27M | $-33M | $-47M | $-36M |
| 稀释后每股收益 (EPS) | $-0.66 | $-0.93 | $-1.27 | $-1.91 | $-2.17 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 3.1 | 7.4 | 2.8 | 1.5 | 0.7 |
| 流动比率 | 5.3 | 5.4 | 5.7 | 8.9 | 14.3 |
| 速动比率 | 4.3 | 4.3 | 4.9 | 7.7 | 13.2 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-11M | $-18M | $-20M | $-37M | $-25M |
机构持有人 (13F) 117 家申报者 · $464.2M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
117
持有价值
$464.2M
新仓位
19
已退出持仓
18
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 19 (-10 与上一季度对比) | 18 (+8 与上一季度对比) | 47 (+9 与上一季度对比) | 35 (0 与上一季度对比) | +120K |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| Polar Capital Holdings Plc | $52406873 | 3298104 | 11.29% | 股份 |
| Soleus Capital Management, L.P. | $46257729 | 2911122 | 9.96% | 股份 |
| First Light Asset Management, LLC | $45463944 | 2861167 | 9.79% | 股份 |
| MORGAN STANLEY | $42178273 | 2654391 | 9.09% | 股份 |
| BlackRock, Inc. | $39369112 | 2477603 | 8.48% | 股份 |
| ORBIMED ADVISORS LLC | $23916436 | 1505125 | 5.15% | 股份 |
| Driehaus Capital Management LLC | $22999043 | 1447391 | 4.95% | 股份 |
| VANGUARD GROUP INC | $22885600 | 1482228 | 4.93% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $19498174 | 1227072 | 4.20% | 股份 |
| DEUTSCHE BANK AG\ | $14919423 | 938919 | 3.21% | 股份 |
| ARMISTICE CAPITAL, LLC | $10995880 | 692000 | 2.37% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $10589998 | 666300 | 2.28% | 股份 |
| Kent Lake PR LLC | $10310000 | 1000000 | 2.22% | 股份 |
| KOTLER KEVIN | $9749866 | 631468 | 2.10% | 股份 |
| FMR LLC | $8815311 | 554771 | 1.90% | 股份 |
| STATE STREET CORP | $8741597 | 550132 | 1.88% | 股份 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $5468130 | 344124 | 1.18% | 股份 |
| NORTHERN TRUST CORP | $4131798 | 260025 | 0.89% | 股份 |
| Qube Research & Technologies Ltd | $3515456 | 221237 | 0.76% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3501695 | 220371 | 0.75% | 股份 |
| Palumbo Wealth Management LLC | $3324173 | 209199 | 0.72% | 股份 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $3316291 | 208703 | 0.71% | 股份 |
| ALGERT GLOBAL LLC | $2936059 | 184774 | 0.63% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $2900465 | 182534 | 0.62% | 股份 |
| JPMORGAN CHASE & CO | $2864831 | 173311 | 0.62% | 股份 |
| HighMark Wealth Management LLC | $2590070 | 163000 | 0.56% | 股份 |
| Russell Investments Group, Ltd. | $2576783 | 162164 | 0.56% | 股份 |
| D. E. Shaw & Co., Inc. | $2559577 | 161081 | 0.55% | 股份 |
| GOLDMAN SACHS GROUP INC | $2376604 | 149566 | 0.51% | 股份 |
| CITADEL ADVISORS LLC | $2046632 | 128800 | 0.44% | 股份 |
| LAZARD ASSET MANAGEMENT LLC | $2029598 | 127728 | 0.44% | 股份 |
| PANAGORA ASSET MANAGEMENT INC | $1812398 | 114059 | 0.39% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $1774897 | 111699 | 0.38% | 股份 |
| TUDOR INVESTMENT CORP ET AL | $1745898 | 109874 | 0.38% | 股份 |
| Nuveen, LLC | $1581023 | 99498 | 0.34% | 股份 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $1506372 | 94800 | 0.32% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $1393188 | 87677 | 0.30% | 股份 |
| Man Group plc | $1335920 | 84073 | 0.29% | 股份 |
| NORGES BANK | $1269611 | 79900 | 0.27% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1236735 | 77831 | 0.27% | 股份 |
| Legato Capital Management LLC | $1117607 | 70334 | 0.24% | 股份 |
| SEI INVESTMENTS CO | $987993 | 62177 | 0.21% | 股份 |
| Bank of New York Mellon Corp | $921255 | 57977 | 0.20% | 股份 |
| TWO SIGMA ADVISERS, LP | $788984 | 51100 | 0.17% | 股份 |
| Informed Momentum Co LLC | $630134 | 39656 | 0.14% | 股份 |
| AQR CAPITAL MANAGEMENT LLC | $570769 | 35920 | 0.12% | 股份 |
| JANE STREET GROUP, LLC | $547220 | 34438 | 0.12% | 股份 |
| RHUMBLINE ADVISERS | $503131 | 31664 | 0.11% | 股份 |
| BARCLAYS PLC | $492765 | 31011 | 0.11% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $486536 | 30619 | 0.10% | 股份 |
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Accelmed Partners II LP, Accelmed Partners II GP, L.P., Accelmed Partners II, LLC, Uri Geiger ×2 申报 | 2022年11月23日 | · | 初始申报 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 17 位内幕人士 · 6 位高管 · 11 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Joel Becker | CHIEF EXECUTIVE OFFICER | 2026年9月3日 F | 138000 | 0 | 0 | $0 |
| Michael Favet | Chief Executive Officer | 2023年2月21日 A | 407080 | 0 | 0 | $0 |
| Patrick F. Williams | Chief Financial Officer | 2026年9月20日 F | 67508 | 0 | 0 | $0 |
| Rebecca Kuhn | CHIEF FINANCIAL OFFICER | 2025年6月3日 F | 131613 | 0 | 0 | $0 |
| Martha Morrell | CHIEF MEDICAL OFFICER | 2026年9月24日 F | 51357 | 0 | 1 | $-399250 |
| Irina Ridley | Chief Legal Officer/Secretary | 2023年2月20日 A | 141139 | 0 | 0 | $0 |
| Rakhi Kumar | 董事 | 2026年6月19日 A | 23039 | 0 | 0 | $0 |
| Uri Geiger | 董事 | 2026年6月19日 A | 18537 | 0 | 0 | $0 |
| Frank M Fischer | 董事 | 2026年6月19日 A | 599534 | 0 | 0 | $0 |
| Renee Ryan | 董事 | 2026年6月5日 A | 2890 | 0 | 0 | $0 |
| Lisa Andrade | 董事 | 2026年6月5日 A | 2890 | 0 | 0 | $0 |
| Scott R Huennekens | 董事 | 2026年6月5日 A | 2890 | 0 | 0 | $0 |
| Joseph Lacob | 董事 | 2026年3月20日 A | 14754 | 0 | 0 | $0 |
| Greg Shaw Garfield | 董事 | 2022年6月13日 A | 5614384 | 0 | 0 | $0 |
| Evan Norton | 董事 | 2021年4月21日 A | 4042657 | 0 | 0 | $0 |
| KCK LTD. | 10% 所有者 | 2025年2月20日 S | 0 | 0 | 0 | $0 |
| Accelmed Partners II L.P. | 10% 所有者 | 2022年11月22日 P | 4432948 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 11 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| IBRN · iShares Trust | 0.38% | 2057 SH | 2026年9月11日 | 每日 |
| IWC · iShares Trust | 0.09% | 89476 SH | 2026年9月11日 | 每日 |
| IWO · iShares Trust | 0.02% | 248901 SH | 2026年9月11日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.02% | 28462 SH | 2026年8月19日 | 每日 |
| IWM · iShares Trust | 0.01% | 676027 SH | 2026年9月11日 | 每日 |
| RSSL · Global X Funds | 0.01% | 12674 NS | 2026年7月31日 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 152437 SH | 2026年8月19日 | 每日 |
| IWV · iShares Trust | 0.00% | 11385 SH | 2026年9月3日 | 每日 |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 290278 SH | 2026年8月19日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 908479 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 1828 SH | 2026年8月19日 | 每日 |
NPCE 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 15 位分析师
买入
中位数目标
$20.00
+57.5%
4 26.7%
强烈买入
10 66.7%
买入
1 6.7%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
10 位分析师 · 2026-10-04平均目标 $20.00 +57.5%
← 低于所有目标
当前价格 $12.70
最低$18.00
平均值$20.00
最高$22.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| NPCE | $518M | -23.4 | 25.1% | -21.5% | -111.6% | 77.2% |
| DCTH | $350M | 144.3 | 129.1% | 3.2% | 2.5% | 86.2% |
| SENS | $228M | -3.3 | 56.9% | -196.0% | -88.7% | 44.7% |
| TCMD | $651M | 35.4 | 12.5% | 5.8% | 9.2% | 75.9% |
| SGHT | $424M | -10.7 | -3.1% | -49.7% | -57.4% | 86.2% |
| SI | $295M | -3.1 | 49.6% | -85.3% | -129.1% | 76.5% |
| CARL | $329M | -5.8 | 85.9% | -58.7% | -375.2% | 75.3% |
| OFIX | $604M | -6.5 | 2.9% | -11.2% | -20.3% | 68.8% |
| OBIO | $237M | -3.7 | 1169.2% | -157.4% | -195.7% | · |
| CLPT | $402M | -15.2 | 17.8% | -69.1% | -106.9% | 61.4% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 11, 2026 申报